Hydroxamic acid derivatives
US8609864B2 · kind B2 · utility
25Cited by
1References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 7, 2010 |
| Grant date | Dec 17, 2013 |
| Priority date | — |
| Expiry date | Jan 7, 2030 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure includes hydroxamic compounds of Formula I: (I) wherein P, Z, and m are defined herein. Also disclosed is a method for treating a neoplastic disease or an immune disease with these compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.